Wählen Sie die Sprache / Choose your language:
Aktuelle Termine


Institut für Virologie
am Department für Hygiene,
Mikrobiologie und Publich Health
der Medizinischen Universität Innsbruck

Peter-Mayr-Straße 4b
A-6020 Innsbruck

Tel.: 0512/9003-71701
Fax: 0512/9003-73701
E-Mail: virologie@i-med.ac.at
Curriculum Vitae

About | Research | Team | Publications | Calendar-News | Links

Curriculum Vitae


Name Dr. med. Guido Wollmann
Date of birth July 20, 1974
Adress Medical University of Innsbruck
Division of Virology
Peter- Mayr- Straße 4b
6020 Innsbruck
Telephone +43 512 9003 71742
Fax +43 512 9003 73701
Email guido.wollmann@i-med.ac.at


1995-2002 Medical Studies, Free University Berlin Medical School (now Charité), Germany
2002 Final medical exam (Staatsexamen)

Scientific Career

2002- 2007 Postdoc, Department of Neurosurgery, Yale University School of Medicine, USA
2007- 2014 Associate Research Scientist, Department of Neurosurgery, Yale University School of Medicine, USA
Since 2014

Group leader for oncolytic virus development at the Division of Virology, Medical University of Innsbruck, Austria


1.Dold C, Urbiola CR,
Wollmann G, Egerer L, Muik A, Bellmann L, Fiegl H, Marth C, Kimpel J & von Laer D. 2016. Application of Interferon Modulators to Overcome Partial Resistance of Human Ovarian Cancers to VSV-GP Oncolytic Viral Therapy. Mol Ther Oncolytics, ACCEPTED.

2.Wollmann G, Drokhlyansky E, Davis JN, Cepko C, van den Pol AN. 2015. Lassa-vesicular stomatitis chimeric virus safely destroys brain tumors. J Virol. 89:6711-24.

3.Wollmann G, Paglino JC, Maloney PR, Ahmadi SA, van den Pol AN. 2015. Attenuation of vesicular stomatitis virus infection of brain using antiviral drugs and an adeno-associated virus-interferon vector. Virology. 475:1-14.

4.Wollmann G, Davis JN, Bosenberg MW, van den Pol AN. 2013. Vesicular stomatitis virus variants selectively infect and kill human melanomas but not normal melanocytes. J Virology. 87:6644-59.

5.Wollmann G, Ozduman K, van den Pol AN. 2012. Oncolytic virus therapy for glioblastoma multiforme: concepts and candidates. Cancer J. 18:69-81.

6.Wollmann G, Rogulin V, Simon I, Rose JK, van den Pol AN. 2010. Some attenuated variants of vesicular stomatitis virus show enhanced oncolytic activity against human glioblastoma cells relative to normal brain cells. J Virology. 84:1563-1573.

7.Ozduman K, Wollmann G, Ahmadi SA, van den Pol AN. 2009. Peripheral immunization blocks lethal actions of vesicular stomatitis virus within the brain. J  Virology. 83:11540-11549.

8.van den Pol AN, Ozduman K, Wollmann G, Ho WS, Simon I, Yao Y, Rose JK, Ghosh P. 2009.  Viral strategies for studying the brain, including a replication-restricted self-amplifying delta-G vesicular stomatis virus that rapidly expresses transgenes in brain and can generate a multicolor golgi-like expression. J Comp Neurol. 516:456-481.

9.Ozduman K, Wollmann G, Piepmeier JM, van den Pol AN. 2008. Systemic vesicular stomatitis virus selectively destroys multifocal glioma and metastatic carcinoma in brain. J Neurosci. 28:1882-1893.

10.Baehring JM, Phipps M, Wollmann G. 2008. Rostral midbrain infarction producing isolated lateropulsion. Neurology. 70:655-656.

11.Wollmann G, Robek MD, van den Pol AN. 2007. Variable deficiencies in the interferon response enhance susceptibility to VSV oncolytic actions in glioblastoma but not in normal human glia. J. Virology. 81:1479-1491.

12.van den Pol AN, Robek MD, Ghosh PK, Ozduman K, Bandi P, Whim MD, Wollmann G. 2007. Cytomegalovirus induces interferon-stimulated gene expression and is attenuated by interferon in the developing brain. J. Virology. 81:332-348.

13.Wollmann G, Lenzner S, Berger W, Rosenthal R, Karl MO, Strauß O. 2006. Voltage-dependent ion channels in the mouse RPE: comparison with Norrie disease mice. Vision Res. 46:688-698.

14.Wollmann, G, Acuna-Goycolea C, van den Pol AN. 2005. Direct excitation of hypocretin/orexin cells by extracellular ATP at P2X receptors. J Neurophysiol. 94:2195-2206.

15.Wollmann G, Tattersall P, van den Pol AN. 2005. Targeting human glioblastoma cells: comparison of nine viruses with oncolytic potential. J. Virology. 79: 6005-6022.

16.Ortego J, Wollmann G, Coca-Prados M. 2002. Differential regulation of gene expression of neurotensin and prohormone convertases PC1 and PC2 in the bovine ocular ciliary epithelium: possible implications on neurotensin processing. Neurosci Lett. 333:49-53.

17.Strauss O, Rosenthal R, Dey D, Beninde J, Wollmann G, Thieme H, Wiederholt M. 2002. Effects of protein kinase C on delayed rectifier K+ channel regulation by tyrosine kinase in rat retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 43:1645-1654.

18.Bertazolli-Filho R, Ghosh S, Huang W, Wollmann G
, Coca-Prados M. 2001. Molecular evidence that human ocular ciliary epithelium expresses components involved in phototransduction. Biochem Biophys Res Commun. 284:317-325.


Book chapters, editorials:

  1. Ozduman K, Wollmann G, Piepmeier. 2010. Gene Therapy for Meningiomas. In: Pamir MN, Black PM, Fahlbusch R, editors. Meningiomas. Philadelphia, Saunders Elsevier. p681-690.
  2. Baehring JM, Wollmann G. 2008. Neurologic Sequelae of Cancer Therapy. In: Miller K., editor. Medical and Psychosocial Care of the Cancer Survivor. Boston: Jones and Bartlett Publishers. p323-340.



Patents approved

"Composition and Methods of use of an Oncolytic Vesicular Stomatitis Virus"

US 8481297

Filed: January 7, 2010

Granted: July 9, 2013


Patent applications submitted

1. "Compositions and Methods for Treating Cancer with Attenuated Oncolytic Viruses"

WO2011056993 / US 20120315248

Filed: 2010

2.“Chimeric VSV Virus Compositions and Methods of Use Thereof for Treatment of Cancer”

U.S.S.N. 61/907,520

Filed: Nov 22, 2013